The Japanese Association for Infectious Diseases

COVID-19 Publications from Japan:Basic research

Last Update: July 7, 2020
Presepsin as a predictive biomarker of severity in COVID-19: a case series.
Author name Fukada A, Kitagawa Y, Matsuoka M, Sakai J, Imai K, Tarumoto N, et al.
Journal title J Med Virol. 2020 Jun 12; 10.1002/jmv.26164. doi: 10.1002/jmv.26164.
Clinicopathologic and immunohistochemical findings from autopsy of patient with COVID-19, Japan.
Author name Adachi T, Chong JM, Nakajima N, Sano M, Yamazaki J, Miyamoto I, et al.
Journal title Emerg Infect Dis. 2020 May 15; 26(9). doi:10.3201/eid2609.201353.
Ehnahced isolation of SARS-CoV-2 by TMPRSS2-expressing cells.
Author name Matsuyama S, Nao N, Shirato K, Kawase M, Saito S, Takayama I, et al.
Journal title Proc Natl Acad Sci USA. 2020 Mar 31; 117(13):7001-3. doi:10.1073/pnas.2002589117.
Protease inhibitors: Candidate drugs to inhibit severe acute respiratory syndrome coronavirus 2 replication.
Author name Yamaya M, Nishimura H, Deng X, Kikuchi A, Nagatomi R.
Journal title Tohoku J Exp Med. 2020 May; 251(1): 27-30. doi:10.1620/tjem.251.27.
Pulmonary surfactant itself must be a strong defender against SARS-CoV-2.
Author name Takano H.
Journal title Med Hypotheses. 2020; 144(2020): 110020.

Copyright © The Japanese Association for Infectious Diseases All Rights Reserved.
To Top